The consequences of the different options for classification of endocrine disruptors presented in the roadmap of the European Commission and by industry were analysed in a case study with natural substances. The results were presented at the Eurotox congress 2016 in Seville (abstract LBA07 and poster).
For further information please contact Ulrike Schuhmacher-Wolz.